Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Brain Diseases

3,4-methylenedioxyamphetamine has been researched along with Brain Diseases in 6 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woodrow, G1
Harnden, P1
Turney, JH1
Saunders, N1
Walker, TM1
Davenport-Jones, JE1
Fox, RM1
Atterwill, CK1
Pearsall, P1
Brüggemann, BR1
Werry, C1
Garlipp, P1
Pfefferer-Wolf, H1
Haltenhof, H1
Enoch, MD1

Reviews

1 review available for 3,4-methylenedioxyamphetamine and Brain Diseases

ArticleYear
Contextual cardiology: what modern medicine can learn from ancient Hawaiian wisdom.
    Cleveland Clinic journal of medicine, 2007, Volume: 74 Suppl 1

    Topics: Brain Diseases; Hawaii; Heart Diseases; Humans; Interpersonal Relations; Love; Medicine, Traditional

2007

Other Studies

5 other studies available for 3,4-methylenedioxyamphetamine and Brain Diseases

ArticleYear
Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy').
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Anemia, Hemolytic; Blood Pressure; Brain

1995
Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.
    BMJ (Clinical research ed.), 1996, Aug-17, Volume: 313, Issue:7054

    Topics: 3,4-Methylenedioxyamphetamine; Brain Diseases; Chronic Disease; Designer Drugs; Humans; Nervous Syst

1996
The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture.
    Cell biology and toxicology, 1999, Volume: 15, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Biomarkers; Brain; Brain Diseases; Cytosol; Deoxyepinephrine

1999
[Erotomania and Frégoli syndrome. A case report].
    Der Nervenarzt, 2002, Volume: 73, Issue:5

    Topics: Adult; Antipsychotic Agents; Brain Diseases; Capgras Syndrome; Delusions; Diagnostic Imaging; Female

2002
Whose double? The psychopathology of the delusional misidentification syndromes, especially the Capgras syndrome.
    Bibliotheca psychiatrica, 1986, Issue:164

    Topics: Adult; Brain Diseases; Capgras Syndrome; Conflict, Psychological; Delusions; Female; Hate; Humans; L

1986